Merck Co Stock Gross Profit
6MK Stock | EUR 95.30 1.20 1.24% |
Merck Co fundamentals help investors to digest information that contributes to Merck's financial success or failures. It also enables traders to predict the movement of Merck Stock. The fundamental analysis module provides a way to measure Merck's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Merck stock.
Merck |
Merck Co Company Gross Profit Analysis
Merck's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Competition |
According to the company disclosure, Merck Co reported 0.0 of gross profit. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Gross Profit (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Merck Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Merck's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Merck could also be used in its relative valuation, which is a method of valuing Merck by comparing valuation metrics of similar companies.Merck is currently under evaluation in gross profit category among its peers.
Merck Fundamentals
Current Valuation | 285.58 B | |||
Price To Book | 6.27 X | |||
Price To Sales | 4.73 X | |||
Revenue | 48.7 B | |||
EBITDA | 17.9 B | |||
Net Income | 13.05 B | |||
Total Debt | 30.69 B | |||
Cash Flow From Operations | 14.11 B | |||
Price To Earnings To Growth | 1.34 X | |||
Market Capitalization | 162.42 B | |||
Total Asset | 105.69 B | |||
Z Score | 3.0 | |||
Annual Yield | 0.02 % | |||
Net Asset | 105.69 B | |||
Last Dividend Paid | 0.55 |
About Merck Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Merck Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Merck using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Merck Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Merck Stock
Merck financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck security.